These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 5877670

  • 1. [On the therapy of osteoporosis with anabolic steroids].
    Krüskemper HL.
    Verh Dtsch Ges Inn Med; 1965; 71():590-6. PubMed ID: 5877670
    [No Abstract] [Full Text] [Related]

  • 2. [Catamnestic results following therapy of heart patients with anabolic steroids].
    Fiegel G, Bargheer R.
    Med Klin; 1966 Nov 25; 61(47):1870-2. PubMed ID: 5989967
    [No Abstract] [Full Text] [Related]

  • 3. Antifracture efficacy of long-term estrogens for osteoporosis.
    Gordan GS, Picchi J, Roof BS.
    Trans Assoc Am Physicians; 1973 Nov 25; 86():326-32. PubMed ID: 4363387
    [No Abstract] [Full Text] [Related]

  • 4. [Use of anabolic hormones for the treatment of cardiovascular patients].
    Zharov EI, Segal' RG.
    Kardiologiia; 1969 Jan 25; 9(1):144-53. PubMed ID: 4896687
    [No Abstract] [Full Text] [Related]

  • 5. [Modification of lipid metabolism by anabolic agents].
    Fiegel G, Bargheer R, Kukwa D.
    Arzneimittelforschung; 1966 Feb 25; 16(2):202-6. PubMed ID: 6014014
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment problems using anabolic steroids in progressive muscular dystrophy].
    Badalian LO, Temin PA, Mukhin KIu.
    Klin Med (Mosk); 1984 Nov 25; 62(11):23-9. PubMed ID: 6394898
    [No Abstract] [Full Text] [Related]

  • 7. Hematological effect of corticosteroids and anabolic steroids on aplastic anemia patients.
    Yamagishi M, Kariyone S, Wakisaka G.
    Nihon Ketsueki Gakkai Zasshi; 1973 Feb 25; 36(1):9-24. PubMed ID: 4738995
    [No Abstract] [Full Text] [Related]

  • 8. [Therapy of osteoporosis].
    Kuhlencordt F.
    Dtsch Med J; 1966 May 05; 17(9):241-7. PubMed ID: 5984282
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. THYROXINE-BINDING BY THE THROXINE-BINDING GLOBULIN AS A MEASURE OF THE ANABOLIC ACTIVITY OF CONGENERS OF TESTOSTERONE.
    OLVEY DN, CUTLER RE, DOWLING JT.
    Metabolism; 1965 Aug 05; 14():891-8. PubMed ID: 14320977
    [No Abstract] [Full Text] [Related]

  • 12. CLINICAL EVALUATION OF A NEW ANABOLIC AGENT 7-ALPHA,17-ALPHA-DIMETHYLTESTOSTERONE (BOLASTERONE).
    KORST DR, BOWERS CY, FLOKSTRA JH, MCMAHON FG.
    Clin Pharmacol Ther; 1963 Aug 05; 4():734-9. PubMed ID: 14079251
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. ANABOLIC STEROIDS: THEIR CLINICAL USE AND SPECIFIC DANGERS IN PEDIATRICS.
    LARON Z, GITTER S.
    Clin Pediatr (Phila); 1963 Nov 05; 2():594-600. PubMed ID: 14085300
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.